Literature DB >> 8929360

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.

R G Nelson1, P H Bennett, G J Beck, M Tan, W C Knowler, W E Mitch, G H Hirschman, B D Myers.   

Abstract

BACKGROUND: Non-insulin-dependent diabetes mellitus (NIDDM) is a major cause of end-stage renal disease. However, the course and determinants of renal failure in this type of diabetes have not been clearly defined.
METHODS: We studied glomerular function at intervals of 6 to 12 months for 4 years in 194 Pima Indians selected to represent different stages in the development and progression of diabetic renal disease. Initially, 31 subjects had normal glucose tolerance, 29 had impaired glucose tolerance, 30 had newly diagnosed diabetes, and 104 had had diabetes for five years or more; of these 104, 20 had normal albumin excretion, 50 had microalbuminuria, and 34 had macroalbuminuria. The glomerular filtration rate, renal plasma flow, urinary albumin excretion, and blood pressure were measured at each examination.
RESULTS: Initially, the mean (+/-SE) glomerular filtration rate was 143+/-7 ml per minute in subjects with newly diagnosed diabetes, 155+/-7 ml per minute in those with microalbuminuria, and 124+/-7 ml per minute in those with macroalbuminuria; these values were 16 percent, 26 percent, and 1 percent higher, respectively, than in the subjects with normal glucose tolerance (123+/-4 ml per minute). During four years of follow-up, the glomerular filtration rate increased by 18 percent in the subjects who initially had newly diagnosed diabetes (P=0.008); the rate declined by 3 percent in those with microalbuminuria at base line (P=0.29) and by 35 percent in those with macroalbuminuria (P<0.001). Higher base-line blood pressure predicted increasing urinary albumin excretion (P=0.006), and higher base-line urinary albumin excretion predicted a decline in the glomerular filtration rate (P<0.001). The initial glomerular filtration rate did not predict worsening albuminuria.
CONCLUSIONS: The glomerular filtration rate is elevated at the onset of NIDDM and remains so while normal albumin excretion or microalbuminuria persists. It declines progressively after the development of macroalbuminuria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929360     DOI: 10.1056/NEJM199611283352203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  124 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 2.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

3.  Renal and glycemic effects of high-dose chromium picolinate in db/db mice: assessment of DNA damage.

Authors:  Mahmood S Mozaffari; Babak Baban; Rafik Abdelsayed; Jun Yao Liu; Hereward Wimborne; Nancy Rodriguez; Worku Abebe
Journal:  J Nutr Biochem       Date:  2011-09-29       Impact factor: 6.048

Review 4.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 5.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 6.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 8.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.

Authors:  Lisbeth V Jacobsen; Charlotte Hindsberger; Richard Robson; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

10.  Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes.

Authors:  P Wei; P H Lane; J T Lane; B J Padanilam; S C Sansom
Journal:  Diabetologia       Date:  2004-08-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.